Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET). (Q35909843)
Jump to navigation
Jump to search
scientific article published on 7 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET). |
scientific article published on 7 November 2012 |
Statements
1 reference
Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET). (English)
1 reference
Toni K Choueiri
1 reference
Sabina Signoretti
1 reference
Suchun Cheng
1 reference
Angela Q Qu
1 reference
Jaromir Pastorek
1 reference
Michael B Atkins
1 reference
7 November 2012
1 reference
1 reference
1788-1793
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference